August 29, 2016 12:13 AM ET

Pharmaceuticals

Company Overview of iTherX, Inc.

Company Overview

iTherX, Inc., a clinical stage pharmaceutical company, discovers and develops antiviral therapeutics for hepatitis C. It provides ITX-5061 to evaluate antiviral activity and safety in patients with hepatitis C virus infection. The company was formerly known as Immusol, Inc. and changed its name to iTherX, Inc. in December 2007. iTherX, Inc. was founded in 1992 and is based in San Diego, California.

700 West East Street

Suite 801

San Diego, CA 92101

United States

Founded in 1992

Phone:

858-222-1568

Fax:

858-824-1112

Key Executives for iTherX, Inc.

Chief Executive Officer, President and Director
Age: 74
Co-founder, Chief Scientific Officer, Executive Vice President of Research & Development and Director
Co-Founder and Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact iTherX, Inc., please visit www.itherx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.